ADR_News_April2024_Vol26_No1HSA Adverse Drug Reaction News 2024 Apr, Vol.26 No.1
The aim of the news bulletin is to increase the awareness of adverse events related to health products amongst healthcare professionals, and to promote adverse event reporting related to health products.
This issue includes the following topics:
- Pseudoephedrine and the rare risk of posterior reversible encephalopathy syndrome (PRES) and reversible cerebral vasoconstriction syndrome (RCVS)
- Analysis of adverse event reports for year 2023
- AE Case in Focus 1 – Test Yourself
- AE Case in Focus 2 – Test Yourself